Recent Quotes (30 days)

You have no recent quotes
chg | %

Thallion Pharmaceuticals Inc  

(Public, TSE:TLN)   Watch this stock  
Find more results for TLN

Officers and directors

Lloyd Mitchell Segal
Executive Chairman of the Board
Allan Mandelzys Ph.D.
Chief Executive Officer, Director
Michael Singer
Chief Financial Officer, Corporate Secretary
Franklin M. Berger
Lead Independent Director
Claude C. Bismuth
Independent Director
Dan Chiche M.D.
Independent Director


Website links

Thallion Pharmaceuticals Inc is a Canada-based biotechnology company. The Company develops pharmaceutical products in the areas of infectious disease and oncology. Thallion Pharmaceuticals Inc’s lead clinical program, Shigamabs, is a dual antibody product for the treatment of Shiga toxin-producing E. coli bacterial infections and has completed a Phase II clinical trial. The Company is a subsidiary of BELLUS Health.

Related companies

* Delayed by up to 20 minutes -  Disclaimer